Steffen Leth
Associate Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (20)
Year:
2026
Year:
2026
Year:
2026
Objectives: People with HIV (PWH) are unable to get private disability insurance on a regular basis in contrast with individuals with other chronic diseases. We aimed to estimate the risk of public disability pension and work absence due to sickness for PWH compared with the background population in Denmark. Design: Nationwide, population-based, matched cohort study of employed PWH with favorable disease characteristics. A comparison cohort of employed individuals was matched 10 : 1 to PWH by date of birth and sex from the general population. Methods: We computed time to first date of 4 weeks of uninterrupted sick leave, 26 weeks of uninterrupted sick leave, and disability pension being granted. We used Cox regression to obtain hazard ratios (HRs) as a measure of relative risk and competing risk analysis to assess absolute risk. Results: After 6 months of observation, PWH had an increased risk of 4-week sick leave, 26-week sick leave and disability pension compared with the comparison cohort (HR of 1.1 [95% CI: 1.0–1.2), 1.4 (95% CI: 1.1–1.6) and 2.0 (95% CI: 1.5–2.6), respectively]. These risks were increased in most patient subgroups. Conclusion: PWH have an increased risk of prolonged sick leave and disability pension, and a slightly increased risk of 4-week sick leave. These risks were within the range of what is described for other chronic diseases. PWH with contemporary cART and favorable disease characteristics should not be generally excluded from access to private disability insurance.
Year:
2026
Background: Mental health has become an area of concern among people with HIV (PWH). We aim to assess whether the risk of schizophrenia spectrum disorders (SSD) is increased among PWH. To examine whether such risks are affected by familial factors we also accessed the risk among their siblings. Methods: Nationwide, population-based, matched cohort study of PWH with Danish origin (1995–2021), a comparison cohort from the background population, matched on date of birth and gender, and sibling cohorts. We used cumulative incidence function and Cox regression to estimate absolute risk and hazard ratios (HR) with 95% confidence intervals (CI) of study outcomes and stratified the results according to route of HIV transmission. Findings: We observed an increased risk of SSD among PWH [20-year cumulative incidence 3.7% vs. 1.0% and HR 4.6 (95% CI: 3.8–5.6)], especially among individuals with injection drug use (IDU) as route of HIV transmission [HR 11.3 (95% CI: 7.7–16.4)]. Among siblings increased risk of SSD was mainly observed among siblings of PWH with IDU as route of HIV transmission [HR of 2.9 (95% CI: 1.9–4.5)] and with lack of statistical power among siblings of PWH with men who have sex with men and heterosexual contact as routes of HIV transmission [HR 1.3 (95% CI: 0.9–1.7) and HR 1.2 (95% CI: 0.7–1.9)]. Interpretation: Risk of SSD is substantially increased among PWH, especially among those who report IDU as route of HIV transmission. Familial risk factors might partly contribute to this risk.
Year:
2026
Year:
2026
Long COVID represents a significant global health challenge with an unclear etiology. Alongside accumulating evidence of mitochondrial dysfunction in patients with acute SARS‐CoV‐2 infection, a symptomatic overlap exists between long COVID and mitochondrial disorders. However, the genetic underpinnings of mitochondrial dysfunction in long COVID have not been previously explored. We employed whole genome sequencing to analyze 13 patients with severe long COVID to identify genetic defects related to mitochondrial function. We performed extracellular bioenergetics flux analysis on peripheral blood mononuclear cells and proteomics to evaluate cellular bioenergetics and compared the results to those of healthy controls. Our investigation identified 10 variants classified as pathogenic or likely pathogenic and 83 variants of unknown significance affecting a wide range of mitochondria‐associated biological functions. Bioenergetics flux analysis in peripheral blood mononuclear cells revealed an altered ATP production rate in four long COVID patients compared to healthy controls. This study presents initial evidence of a potential underlying genetic predisposition to mitochondrial dysfunction in long COVID while demonstrating altered cellular energy capacity in a subset of these patients. These findings open avenues for further research into the role of mitochondrial dysfunction and pathology in patients suffering from long COVID and may pave the way for targeted therapeutic strategies aimed at mitigating mitochondrial dysfunction.
Year:
2025
Year:
2025
Introduction The Post-COVID-19 Functional Status (PCFS) scale was quickly adopted into COVID-19 research and clinical practice worldwide to monitor functional status and recovery. The scale has been translated into Danish, and three different administration methods have been employed. However, clinicians have expressed concerns about the scale's ability to capture work-related functional limitations. Therefore, the purpose of this study was to evaluate the construct validity of three different administration methods of the Danish version of the PCFS scale. Methods This cross-sectional study included patients with long COVID who completed three versions of the PCFS scale: a questionnaire-based version, a flowchart-based version, and an interview-based version. The construct validity was evaluated following the Consensus-based Standards for the selection of health Measurement Instruments (COSMIN) guidelines by testing predefined hypotheses that compared the PCFS scale with sick leave and EuroQoL Five-dimensions Five level (EQ-5D-5l). Results A total of 437 patients, with a mean age 48 years, 75% female, and 59% on sick leave, were included in this study. Statistically significant differences between the three administration methods were found. Of the 234 patients on sick leave, only 50%-54% had a PCFS grade ≥3 which was below our predefined hypothesis. Furthermore, correlations between the PCFS scale and EQ-5D-5l was lower than hypothesized. Conclusion None of the three administration methods effectively captured work-related functional limitations associated with being on part-time or full-time sick leave. Additionally, correlations with quality of life were lower than expected. Overall, the construct validity of the PCFS scale was only partially supported.
Year:
2025
Myasthenic crisis is a severe complication of myasthenia gravis (MG) characterized by respiratory failure. This case report presents a 24-year-old woman admitted with respiratory distress, eventually diagnosed with myasthenic crisis triggered by COVID-19. Initial symptoms included throat pain and dysphagia with no evident pathology. Elevated acetylcholine receptor antibodies confirmed MG. The case underscores the importance of considering neuromuscular diseases in unexplained respiratory failure, highlighting early diagnosis and treatment as key to reducing the need for invasive ventilation.
Year:
2025
Year:
2025
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Collaborators (33)
nilanjan dey
Aarhus University
Søren Sperling
Aarhus University
Sofie Eg Jørgensen
Assistant professor
Aarhus University
Michael Dalager-Pedersen
Aalborg University
Pelle Trier Petersen
Zealand University Hospital
Martin Tolstrup
Professor
Aarhus University
Kristoffer Skaalum Hansen
Aarhus University
Anne-Mette Lebech
Københavns Universitet
Jesper Falkesgaard Højen
Aarhus University
Jens Bukh
Professor
Københavns Universitet
Peer Brehm Christensen
University of Southern Denmark
Johan Palmfeldt
VIP, Associate Professor
Aarhus University
Ida Monrad Johannsen
Aarhus University
Lotte Sørensen
DVIP-part-time lecturer, Part-time Lecturer
Aarhus University
Morten Kelder Skouboe
Aarhus University
Jesper Gunst
VIP, Associate Professor
Aarhus University
Britta Tarp
Consultant, PhD, Associate professor, DTM&H
Aarhus University
Jillian Lau
Peter Doherty Institute
Johannes Schmid
VIP, Clinical Associate Professor
Aarhus University
Jane Agergaard
Aarhus University Hospital
Andreas Fløe
VIP, Clinical Associate Professor
Aarhus University
Lars H Omland
Copenhagen University Hospital
Lisa Gregersen Oestergaard
VIP, Associate Professor
Aarhus University
Isik Somuncu Johansen
University of Southern Denmark
Paul Denton
Associate Professor
University of Nebraska Omaha
Lars Østergaard
Professor
Aarhus University
Thomas Aagaard Rasmussen
Aarhus University Hospital
Charlotte Hyldgaard
VIP, Clinical Associate Professor
Aarhus University
Dorthe Sørensen
DVIP-part-time lecturer, Part-time Lecturer
Aarhus University
Trine Hyrup Mogensen
DVIP-external, Professor
Aarhus University
Claus Vinther Nielsen
VIP, Professor
Aarhus University
Merete Storgaard
VIP, Clinical Associate Professor
Aarhus University
Berit Schiøttz Christensen
Professor
University of Southern Denmark
Make your next move.
Prepare your application
Review drafts before you send them.